Cancer and immune cells evolutionary trajectories under treatment with the aromatase inhibitor letrozole and the CDK4/6 inhibitor ribociclib

被引：0
|
作者：
Fongard, Marie
Schmiester, Leonard
Ghannoum, Salim
Bjornstad, Marius
Bosnjak, Tatjana
Kleivbo, Signe
Selsas, Knut
Geisler, Stephanie
Fjermeros, Kamilla
Bhargava, Sameer
Seyedzadeh, Manouchehr
Buvarp, Unn-Cathrin
Vuoriluoto, Aino
Nam Thi Nguyen
Luders, Torben
Lambrechts, Diether
Lyngra, Marianne
Frigessi, Arnoldo
Kristensen, Vessela
Geisler, Jurgen
Tekpli, Xavier
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-23-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-23-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Single cell characterization of longitudinal biopsies from breast cancer patients treated with the aromatase inhibitor letrozole and the CDK4/6 inhibitor ribociclib
    Tekpli, X.
    Ghannoum, S.
    Steen, C. B.
    Fongard, M.
    Holm, B. C.
    Bosnjak, T.
    Reitsma, L. C.
    Geisler, S. B.
    Seyedzadeh, M.
    Buvarp, U-C.
    Loeng, M.
    Lyngra, M.
    Kristensen, V.
    Geisler, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1314 - S1315
  • [2] Single cell characterization of longitudinal biopsies from breast cancer patients treated neoadjuvantly with the aromatase inhibitor letrozole and the CDK4/6 inhibitor ribociclib in concert
    Fongard, Marie
    Steen, Chloe
    Ghannoum, Salim
    Bjornstad, Marius
    Holm, Barbro
    Bosnjak, Tatjana
    Reitsma, Laurens
    Geisler, Stephanie
    Fjermeros, Kamilla
    Bruteig, Johannes
    Seyedzadeh, Manouchehr
    Buvarp, Unn-Cathrin
    Loeng, Marie
    Vuoriluoto, Aino
    Luders, Torben
    Lambrechts, Diether
    Lyngra, Marianne
    Kristensen, Vessela
    Geisler, Jurgen
    Tekpli, Xavier
    CANCER RESEARCH, 2023, 83 (05)
  • [3] Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells
    Choupani, Edris
    Madjd, Zahra
    Saraygord-Afshari, Neda
    Kiani, Jafar
    Hosseini, Arshad
    PLOS ONE, 2022, 17 (12):
  • [4] Influence of the CDK4/6 Inhibitor Ribociclib on the peripheral Immune Response in Hormone Receptor Positive Breast Cancer
    Peuker, C. A.
    Yaghobramzi, S.
    Lueftner, D.
    Brucker, S.
    Decker, T.
    Fasching, P.
    Fehm, T.
    Janni, W.
    Kummel, S.
    Schneeweiss, A.
    Schuler, M.
    Busse, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E53 - E53
  • [5] Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
    Chen, Fengquan
    Liu, Chunxi
    Zhang, Jian
    Xu, Wenfang
    Zhang, Yingjie
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (09) : 1241 - 1251
  • [6] Feasibility of treatment with another CDK4/6 inhibitor after severe ribociclib liver toxicity
    Zurcher, Jean-Philippe
    Goujon, Morgan
    Cottu, Paul H.
    Desmoulins, Isabelle
    Teixeira, Luis
    Mansi, Laura
    Meynard, Guillaume
    Dobi, Erion
    Rowinski, Elise
    Stacoffe, Marion
    Augereau, Paule
    Robert, Marie
    Mottaz, Yann
    Gaiffe, Anais
    Grandvuillemin, Aurelie
    Fleury, Mapi
    Dolcan, Ana
    Stravodimou, Athina
    Zaman, Khalil
    Curtit, Elsa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Different mechanism of CDK4/6 inhibitor resistance between ribociclib and abemaciclib
    Iida, Masafumi
    Toyosawa, Daichi
    Nakamura, Misato
    Tokuda, Emi
    Niwa, Toshifumi
    Yoshida, Ryuichi
    Ishida, Takanori
    Hayashi, Shin-ichi
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer
    Palumbo, Alison
    Lau, Gary
    Saraceni, Megan
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (02) : 178 - 185
  • [9] Reprogramming human cancer cells in CDK4/6 inhibitor therapy
    Chen-Kiang, Selina
    Di Liberto, Maurizio
    Vijay, Priyanka
    Chiron, David
    Huang, Xiangao
    Ely, Scott
    Elemento, Olivier
    Mason, Christopher
    Cantley, Lewis
    Leonard, John P.
    Martin, Peter
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [10] Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
    Martin, Miguel
    Garcia-Saenz, Jose A.
    Manso, Luis
    Llombart, Antonio
    Cassinello, Alejo
    Atienza, Manuel
    Ringeisen, Francois
    Ciruelos, Eva
    FUTURE ONCOLOGY, 2020, 16 (33) : 2763 - 2778
12345